Home » Chinese Healthcare Investors »


|| Chinese firm invested $12 million in UK company Blueberry Therapeutics

china-uk-therChinese firm China Medical System Holdings is investing $12 million in UK healthcare firm Blueberry Therapeutics.

Established in 2011, Blueberry Therapeutics is a UK-based drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections. China Medical System Holdings is a specialty pharmaceutical company based in China, focusing on marketing, promotion and sales of prescription drugs and other medicinal products. (More details here.)

To see a listing and email addresses of investors from China similar to China Medical System Holdings, check the Chinese Investors Directory.



Previous Post: Chinese private equity firm to invest $270 million in blockchain firm tZero
Next Post: Chinese firm Fosun invests $5 million in Israeli fintech startup

More from Chinese Healthcare Investors ...


  Chinese firm invested $12 million in UK company Blueberry Therapeutics

  Chinese investors acquired SciClone Pharmaceuticals for $605 million

  Chinese firm acquired Canada Iovate Health for $730 million

  Chinese investors acquired Australian vitamin maker Vitaco for $239 million

  Chinese investors of ORI Capital invested $18 million in Boston firm Pillar Biosciences

  Chinese investors of Citic acquired stake at Singapore medical firm for $817 million

  Chinese Hepalink acquired US Cytovance Biologics for $205 million

  Chinese investors acquired stake at Israeli biotech firm for $3 million

  Chinese investors of LongTec invested $10 million in RealView Imaging

  Chinese Decheng Capital and consortium invested $120 million in California genetics firm





| About Us

Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.



|Subscribe to mailing list

Enter your email address:



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2022     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn